The SSA is pleased to announce that Dr Sharon Cox is the winner of the 2024 Impact Prize, in recognition of her work to address health inequalities in smoking cessation interventions.
Dr Sharon Cox is Principal Research Fellow in Behavioural Science and Health in the Tobacco and Alcohol Research Group at UCL (UTARG), Deputy Director of Behaviour Research UK (BRUK), and President of the European Chapter of the Society for Research on Nicotine and Tobacco (SRNT-E).
Sharon’s research focuses on treatment for tobacco dependence within communities facing severe and multiple disadvantages, and how social determinants can influence uptake and use of mainstream smoking cessation treatments and act as wider barriers to tobacco harm reduction.
The SSA selected Sharon has the 2024 winner of the Impact Prize for her broad portfolio of work on smoking, and success in directly influencing policy by securing investment in smoking cessation interventions for people experiencing homelessness.
The judging panel noted that Sharon’s work helps to advance the strategic aims of the Society, and described her as an “excellent researcher with a very good track record and engagement with policy”, who has “achieved impact in an area which is less ‘newsworthy’ than some aspects of addiction”.
Congratulations to Dr Sharon Cox from everyone at the SSA.
The opinions expressed in this post reflect the views of the author(s) and do not necessarily represent the opinions or official positions of the SSA.
The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility.
